FDA Slaps Tighter Controls On COVID-19 Antibody Tests
The U.S. Food and Drug Administration announced Monday that commercial manufacturers of antibody tests for COVID-19 will now be required to submit emergency use authorization requests, a change from a March...To view the full article, register now.
Already a subscriber? Click here to view full article